- Home
- KIDS vs LAB Comparison
KIDS vs LAB Comparison
Compare KIDS & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KIDS | LAB |
|---|---|---|
| Founded | 2007 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 452.9M | 488.4M |
| IPO Year | 2016 | 2008 |
Fundamental Metrics
Financial Performance| Metric | KIDS | LAB |
|---|---|---|
| Price | $17.64 | $0.97 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 1 |
| Target Price | ★ $24.67 | $1.35 |
| AVG Volume (30 Days) | 119.4K | ★ 2.3M |
| Earning Date | 01-01-0001 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 44.68 |
| EPS | N/A | ★ N/A |
| Revenue | $98,049,000.00 | ★ $101,937,000.00 |
| Revenue This Year | $14.07 | N/A |
| Revenue Next Year | $11.85 | $2.63 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 37.95 | N/A |
| 52 Week Low | $15.34 | $0.92 |
| 52 Week High | $26.40 | $1.72 |
Technical Indicators
Market Signals| Indicator | KIDS | LAB |
|---|---|---|
| Relative Strength Index (RSI) | 50.46 | 26.49 |
| Support Level | $17.62 | N/A |
| Resistance Level | $19.36 | $1.41 |
| Average True Range (ATR) | 1.03 | 0.07 |
| MACD | 0.06 | -0.00 |
| Stochastic Oscillator | 46.31 | 5.82 |
Price Performance
Historical ComparisonAbout KIDS OrthoPediatrics Corp.
OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercialize implants and instruments to meet the needs of surgeons and patients. Its products, include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia and ACL Reconstruction System among others.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.